The House of Representatives has voted 283 – 132 to approve legislation (HR 184) that would permanently repeal the Affordable Care Act's 2.3% excise tax on the sale of certain medical devices. While a government funding bill approved by Congress in February 2018 blocked imposition of the tax in 2018 and 2019, permanent repeal has been a top priority of the medical technology industry. It is uncertain, however, whether the Senate will take up the bill this year.
This article is presented for informational purposes only and is not intended to constitute legal advice.
